Wnt/β-catenin signaling in cancer stemness and malignant behavior

Current Opinion in Cell Biology

Volumn 19, Issue 2, 2007, Pages 150-158

  Fodde, Riccardo ^a   Brabletz, Thomas ^b  

^a JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; WNT PROTEIN;

CANCER STEM CELL; CARCINOGENESIS; CELL DIFFERENTIATION; CELLULAR DISTRIBUTION; COLORECTAL CANCER; GENE FUNCTION; GENE MUTATION; MALIGNANT TRANSFORMATION; METASTASIS; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

ANIMALS; BETA CATENIN; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; MESENCHYMAL STEM CELLS; MODELS, BIOLOGICAL; NEOPLASMS; SIGNAL TRANSDUCTION; TUMOR STEM CELLS; WNT PROTEINS;

EID: 33847740988     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ceb.2007.02.007     Document Type: Review

References (49)

1. Fodde R., Smits R., and Clevers H. APC, signal transduction and genetic instability in colorectal cancer. Nat Rev Cancer 1 (2001) 55-67
2. Korinek V., Barker N., Morin P.J., van Wichen D., de Weger R., Kinzler K.W., Vogelstein B., and Clevers H. Constitutive transcriptional activation by a β-catenin-Tcf complex in APC-/- colon carcinoma. Science 275 (1997) 1784-1787
3. Morin P.J., Sparks A.B., Korinek V., Barker N., Clevers H., Vogelstein B., and Kinzler K.W. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 275 (1997) 1787-1790
4. van de Wetering M., Sancho E., Verweij C., de Lau W., Oving I., Hurlstone A., van der Horn K., Batlle E., Coudreuse D., Haramis A.P., et al. The β-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111 (2002) 241-250
5. Lowry W.E., Blanpain C., Nowak J.A., Guasch G., Lewis L., and Fuchs E. Defining the impact of β-catenin/Tcf transactivation on epithelial stem cells. Genes Dev 19 (2005) 1596-1611. By employing gain-of-function mutations and inducible loss-of-function mutations, the authors show that different levels of Wnt/β-catenin signaling have distinct effects on stem cells of the hair follicle and their transient amplifying progenitors.
6. Woodward W.A., Chen M.S., Behbod F., and Rosen J.M. On mammary stem cells. J Cell Sci 118 (2005) 3585-3594
7. Reya T., Duncan A.W., Ailles L., Domen J., Scherer D.C., Willert K., Hintz L., Nusse R., and Weissman I.L. A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature 423 (2003) 409-414
8. Alonso L., and Fuchs E. Stem cells in the skin: waste not, Wnt not. Genes Dev 17 (2003) 1189-1200
9. Li Y., Welm B., Podsypanina K., Huang S., Chamorro M., Zhang X., Rowlands T., Egeblad M., Cowin P., Werb Z., et al. Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells. Proc Natl Acad Sci USA 100 (2003) 15853-15858
10. Reya T., and Clevers H. Wnt signalling in stem cells and cancer. Nature 434 (2005) 843-850
11. Brabletz T., Jung A., Hermann K., Gunther K., Hohenberger W., and Kirchner T. Nuclear overexpression of the oncoprotein beta-catenin in colorectal cancer is localized predominantly at the invasion front. Pathol Res Pract 194 (1998) 701-704
12. Jung A., Schrauder M., Oswald U., Knoll C., Sellberg P., Palmqvist R., Niedobitek G., Brabletz T., and Kirchner T. The invasion front of human colorectal adenocarcinomas shows co-localization of nuclear β-catenin, cyclin D1, and p16INK4A and is a region of low proliferation. Am J Pathol 159 (2001) 1613-1617
13. Brabletz T., Jung A., Reu S., Porzner M., Hlubek F., Kunz-Schughart L.A., Knuechel R., and Kirchner T. Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc Natl Acad Sci USA 98 (2001) 10356-10361
14. Kirchner T., and Brabletz T. Patterning and nuclear beta-catenin expression in the colonic adenoma-carcinoma sequence. Analogies with embryonic gastrulation. Am J Pathol 157 (2000) 1113-1121
15. Brabletz T., Jung A., Spaderna S., Hlubek F., and Kirchner T. Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression. Nat Rev Cancer 5 (2005) 744-749
16. Gaspar C., and Fodde R. APC dosage effects in tumorigenesis and stem cell differentiation. Int J Dev Biol 48 (2004) 377-386
17. Reya T., Morrison S.J., Clarke M.F., and Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature 414 (2001) 105-111
18. Zhang B., Ougolkov A., Yamashita K., Takahashi Y., Mai M., and Minamoto T. β-Catenin and ras oncogenes detect most human colorectal cancer. Clin Cancer Res 9 (2003) 3073-3079
19. Janssen K.P., Alberici P., Fsihi H., Gaspar C., Breukel C., Franken P., Rosty C., Abal M., El Marjou F., Smits R., et al. APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression. Gastroenterology 131 (2006) 1096-1109. This paper provides in vivo and in vitro evidence of the synergistic interaction between oncogenic KRAS and loss of APC function in enhancing β-catenin nuclear accumulation and Wnt signaling in intestinal cancer onset and progression to malignancy.
20. Kinch M.S., Clark G.J., Der C.J., and Burridge K. Tyrosine phosphorylation regulates the adhesions of ras-transformed breast epithelia. J Cell Biol 130 (1995) 461-471
21. Rajagopalan H., Bardelli A., Lengauer C., Kinzler K.W., Vogelstein B., and Velculescu V.E. Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status. Nature 418 (2002) 934
22. Bardelli A., Parsons D.W., Silliman N., Ptak J., Szabo S., Saha S., Markowitz S., Willson J.K., Parmigiani G., Kinzler K.W., et al. Mutational analysis of the tyrosine kinome in colorectal cancers. Science 300 (2003) 949
23. Wang Z., Shen D., Parsons D.W., Bardelli A., Sager J., Szabo S., Ptak J., Silliman N., Peters B.A., van der Heijden M.S., et al. Mutational analysis of the tyrosine phosphatome in colorectal cancers. Science 304 (2004) 1164-1166
24. Bafico A., Liu G., Goldin L., Harris V., and Aaronson S.A. An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells. Cancer Cell 6 (2004) 497-506. The authors demonstrate the existence of an autocrine loop for canonical Wnt signaling in human breast, ovarian and colorectal cancer cells.
25. Shulewitz M., Soloviev I., Wu T., Koeppen H., Polakis P., and Sakanaka C. Repressor roles for TCF-4 and Sfrp1 in Wnt signaling in breast cancer. Oncogene 25 (2006) 4361-4369
26. Lin S.Y., Xia W., Wang J.C., Kwong K.Y., Spohn B., Wen Y., Pestell R.G., and Hung M.C. β-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression. Proc Natl Acad Sci USA 97 (2000) 4262-4266
27. De Wever O., Nguyen Q.D., Van Hoorde L., Bracke M., Bruyneel E., Gespach C., and Mareel M. Tenascin-C and SF/HGF produced by myofibroblasts in vitro provide convergent pro-invasive signals to human colon cancer cells through RhoA and Rac. FASEB J 18 (2004) 1016-1018
28. Gregorieff A., Pinto D., Begthel H., Destree O., Kielman M., and Clevers H. Expression pattern of Wnt signaling components in the adult intestine. Gastroenterology 129 (2005) 626-638
29. Ormestad M., Astorga J., Landgren H., Wang T., Johansson B.R., Miura N., and Carlsson P. Foxf1 and Foxf2 control murine gut development by limiting mesenchymal Wnt signaling and promoting extracellular matrix production. Development 133 (2006) 833-843. By targeting murine Foxf1 and Foxf2, which encode forkhead transcription factors, the authors show that these mesenchymal factors control epithelial proliferation and survival, and link hedgehog to Bmp and Wnt signaling.
30. Kaestner K.H., Silberg D.G., Traber P.G., and Schutz G. The mesenchymal winged helix transcription factor Fkh6 is required for the control of gastrointestinal proliferation and differentiation. Genes Dev 11 (1997) 1583-1595
31. Perreault N., Katz J.P., Sackett S.D., and Kaestner K.H. Foxl1 controls the Wnt/β-catenin pathway by modulating the expression of proteoglycans in the gut. J Biol Chem 276 (2001) 43328-43333
32. Perreault N., Sackett S.D., Katz J.P., Furth E.E., and Kaestner K.H. Foxl1 is a mesenchymal Modifier of Min in carcinogenesis of stomach and colon. Genes Dev 19 (2005) 311-315. The authors show that loss of the mesenchymal transcription factor Foxl1 leads to a marked increase in tumor numbers in the colon of Apc(Min) mice. This is the first example of a mesenchymal modifier of Apc-driven tumorigenesis.
33. Wielenga V.J., van der Voort R., Taher T.E., Smit L., Beuling E.A., van Krimpen C., Spaargaren M., and Pals S.T. Expression of c-Met and heparan-sulfate proteoglycan forms of CD44 in colorectal cancer. Am J Pathol 157 (2000) 1563-1573
34. Rasola A., Fassetta M., De Bacco F., D'Alessandro L., Gramaglia D., Di Renzo M.F., and Comoglio P.M. A positive feedback loop between hepatocyte growth factor receptor and beta-catenin sustains colorectal cancer cell invasive growth. Oncogene (2006). In this paper, the authors demonstrate that functional crosstalk exists in colorectal cancer between MET and Wnt/β-catenin signaling. HGF stimulation of colorectal cancer cells triggers β-catenin tyrosine phosphorylation and its dissociation from MET, thus leading to its nuclear accumulation and increasing invasive properties.
35. Heldin C.H., and Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 79 (1999) 1283-1316
36. Yang L., Lin C., and Liu Z.R. P68 RNA helicase mediates PDGF-induced epithelial mesenchymal transition by displacing axin from β-catenin. Cell 127 (2006) 139-155. The authors demonstrate a novel mechanism involving the RNA helicase p68 in mediating EMT and tumor invasion. PDGF stimulation of colorectal cancer cells results in tyrosine phosphorylation of p68. Tyr-P p68 binds β-catenin and facilitates its signaling to the nucleus by inhibiting GSK3β phosphorylation and by displacing Axin from β-catenin.
37. He X. Unwinding a path to nuclear β-catenin. Cell 127 (2006) 40-42
38. Smith K., Bui T.D., Poulsom R., Kaklamanis L., Williams G., and Harris A.L. Up-regulation of macrophage wnt gene expression in adenoma-carcinoma progression of human colorectal cancer. Br J Cancer 81 (1999) 496-502
39. Brown J.R., and DuBois R.N. COX-2: a molecular target for colorectal cancer prevention. J Clin Oncol 23 (2005) 2840-2855
40. Castellone M.D., Teramoto H., Williams B.O., Druey K.M., and Gutkind J.S. Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-β-catenin signaling axis. Science 310 (2005) 1504-1510. A link is established between proinflammatory metabolites and Wnt signaling activation in promoting tumor growth. The authors show that PGE2 stimulates colon cancer cell growth through a signaling route that leads to the inactivation and release of GSKβ from the destruction complex with axin, thereby activating Wnt signaling.
41. Niemann C. Controlling the stem cell niche: right time, right place, right strength. Bioessays 28 (2006) 1-5
42. Brembeck F.H., Rosario M., and Birchmeier W. Balancing cell adhesion and Wnt signaling, the key role of beta-catenin. Curr Opin Genet Dev 16 (2006) 51-59
43. Brembeck F.H., Schwarz-Romond T., Bakkers J., Wilhelm S., Hammerschmidt M., and Birchmeier W. Essential role of BCL9-2 in the switch between β-catenin's adhesive and transcriptional functions. Genes Dev 18 (2004) 2225-2230. The switch between β-catenin's adhesive and transcriptional functions is here shown to be modulated by Tyr-phosphorylation of β-catenin, which favors BCL9-2 binding and precludes interaction with α-catenin. Thus, BCL9-2 induces EMT of non-transformed cells by increasing Wnt/β-catenin signaling.
44. Adachi S., Jigami T., Yasui T., Nakano T., Ohwada S., Omori Y., Sugano S., Ohkawara B., Shibuya H., Nakamura T., et al. Role of a BCL9-related β-catenin-binding protein, B9L, in tumorigenesis induced by aberrant activation of Wnt signaling. Cancer Res 64 (2004) 8496-8501. BCL9-2 is required for enhanced β-catenin-TCF-mediated transcription in colorectal cancer cells and for their malignant transformation. BCL9-2 expression is shown to be up-regulated in ∼40% of colorectal tumors when compared to non-cancerous tissues.
45. Sakamoto I., Ohwada S., Toya H., Togo N., Kashiwabara K., Oyama T., Nakajima T., Ito H., Adachi S., Jigami T., et al. Up-regulation of a BCL9-related β-catenin-binding protein, B9L, in different stages of sporadic colorectal adenoma. Cancer Sci (2006)
46. Yook J.I., Li X.Y., Ota I., Hu C., Kim H.S., Kim N.H., Cha S.Y., Ryu J.K., Choi Y.J., Kim J., et al. A Wnt-Axin2-GSK3β cascade regulates Snail1 activity in breast cancer cells. Nat Cell Biol (2006). This study demonstrates that canonical Wnt signaling prompts tumor cell de-differentiation and tissue invasion through an Axin2-dependent pathway that stabilizes Snail1, a key regulator of normal and neoplastic EMT programs. Axin2 regulates EMT by controlling intracellular distribution of GSK3β, the kinase responsible for controlling Snail1 protein turnover and activity.
47. Jope R.S., and Johnson G.V. The glamour and gloom of glycogen synthase kinase-3. Trends Biochem Sci 29 (2004) 95-102
48. Salahshor S., and Woodgett J.R. The links between axin and carcinogenesis. J Clin Pathol 58 (2005) 225-236
49. Sjoblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D., Mandelker D., Leary R.J., Ptak J., Silliman N., et al. The consensus coding sequences of human breast and colorectal cancers. Science 314 (2006) 268-274